Funding Opportunities

• FY23 Multiple Sclerosis Research Program (MSRP): Clinical Trial Award
  Pre-Application (Preproposal): June 8, 2023 5:00 p.m. Eastern time; Application Deadline: October 6, 2023
  Funding Level 1: Supports early-phase, proof-of-principle clinical trials to demonstrate feasibility or inform the design of more advanced trials, or other clinical trials that are appropriate for this Funding Level. • Funding Level 2: Supports larger-scale clinical trials at phase 1 or 2 that seek to show preliminary evidence of safety or efficacy (benefit on clinical or paraclinical outcomes) in relevant patient populations. • Scientific rationale and preliminary data are required.
• FY23 Multiple Sclerosis Research Program (MSRP): Exploration – Hypothesis Development Award
  Pre-Application (Preproposal): June 8, 2023 5:00 p.m. Eastern time; Application Deadline: October 6, 2023
  Supports the initial exploration of innovative, high-risk, high-gain, and potentially groundbreaking concepts in the MS research field. • Preliminary data are not required. • Clinical trials are not allowed. • New Investigator Option supports applicants early in their faculty appointments. • Research must address at least one of the following Focus Areas: ○ Central Nervous System Repair, Protection, and Regenerative Potential in Multiple Sclerosis ○ Correlates of Disease Activity and Progression in Multiple Sclerosis ○ Biology and Measurement of Multiple Sclerosis Symptoms ○ Factors Contributing to or Associated with Multiple Sclerosis Etiology, Prodrome, Onset, and Disease Course
• FY23 Multiple Sclerosis Research Program (MSRP): Investigator-Initiated Research Award
  Pre-Application (Preproposal): June 8, 2023 5:00 p.m. Eastern time; Application Deadline: October 6, 2023
  Supports highly rigorous, high-impact research with the potential to make an important contribution to MS research and/or patient care. • Preliminary data are required. • Clinical trials are not allowed. • New Investigator Option supports applicants early in their faculty appointments. • Research must address at least one of the following Focus Areas: ○ Central Nervous System Repair, Protection, and Regenerative Potential in Multiple Sclerosis ○ Correlates of Disease Activity and Progression in Multiple Sclerosis ○ Biology and Measurement of Multiple Sclerosis Symptoms ○ Factors Contributing to or Associated with Multiple Sclerosis Etiology, Prodrome, Onset, and Disease Course
• FY23 Joint Warfighter Medical Research Program (JWMRP): Military Medical Research and Development Award (MMRDA)
  Pre-Application (Preproposal): June 15, 2023 at 5:00 p.m. Eastern Time (ET); Application Deadline: September 7, 2023
  Pre-application submission is required; application submission is by invitation only. • Applicants must have already received DOD core or DOD congressionally-directed prior year funding for the same research and/or development project being proposed for logical continuation under this funding opportunity. Maximum funding of $2.3M for total costs (direct plus indirect costs).
• Peer Reviewed Orthopaedic Research Program (PRORP): Applied Research Award (ARA)
  Pre-Application (Preproposal): June 15, 2023 at 5:00 p.m. Eastern Time; Application Deadline: September 13, 2023
  Supports applied research applications focused on advancing optimal treatment and restoration of function for individuals with musculoskeletal injuries sustained during combat and service-related activities. • Proposed research should be supported by preliminary and/or published data and have the potential to advance toward clinical translation. The maximum allowable funding for the entire period of performance is $750,000 in total costs.
• Peer Reviewed Orthopaedic Research Program (PRORP): Clinical Trial Award (CTA)
  Pre-Application (Preproposal): June 15, 2023 at 5:00 p.m. Eastern Time; Application Deadline: September 13, 2023
  Supports the rapid implementation of clinical trials with the potential to have a significant impact on treatment or management of military combat or service-related orthopaedic injuries that significantly impact unit readiness and return to duty/work rates. • Funding must support a clinical trial and may not be used for animal or preclinical research studies. • Investigational New Drug or Investigational Device Exemption applications, if needed, should be submitted to the Food and Drug Administration or other relevant national regulatory agency within 6 months of the award date. The maximum allowable funding for the entire period of performance is $2.5 million (M) in total costs.
• Peer Reviewed Orthopaedic Research Program (PRORP): Clinical Translational Research Award (CTRA)
  Pre-Application (Preproposal): June 15, 2023 at 5:00 p.m. Eastern Time; Application Deadline: September 13, 2023
  Supports high-impact and/or new/emerging clinical research that may not be ready for a full-scale randomized controlled clinicaltrial. • Funding must support clinical research studies involving humans. • Animal research is not allowed under this mechanism. • Preliminary data relevant to the proposed research project are required. • Investigational New Drug or Investigational Device Exemption applications, if needed, should be submitted to the Food and Drug Administration or other relevant national regulatory agency within 12 months of the award date. The maximum allowable funding for the entire period of performance is $1.5M in total costs.
• Bone Marrow Failure Research Program (BMFRP): Idea Development Award (IDA)
  Letter of Intent: June 21, 2023 5:00 p.m. Eastern Time (ET); Application Deadline: September 20, 2023
  Supports innovative ideas and high-impact approaches based on scientifically sound evidence to move toward the vision to understand and cure bone marrow failure (BMF) diseases. • Proposed research should have a high probability of revealing new avenues of investigation. • Research project should include a wellformulated, testable hypothesis and a welldeveloped and articulated research approach. • Must address at least one of the FY23 BMFRP Focus Areas. • Strong BMF research team. • May include relevant preliminary data. • Clinical trials are not allowed. • Translational. The maximum allowable funding for the entire period of performance is $530,000 for direct costs.
• Bone Marrow Failure Research Program (BMFRP): Investigator-Initiated Research Award (IIRA)
  Letter of Intent: June 21, 2023 5:00 p.m. Eastern Time (ET); Application Deadline: September 20, 2023
  Two funding levels of intent: ○ Funding Level 1 (FL): Supports studies that further develop mature ideas, expand upon key discoveries, and have the potential to make significant advances in BMF research and patient care. Correlative studies to existing clinical trials/studies are encouraged. Translational potential should be considered and described. ○ Funding Level 2: Investigational New Drug (IND)-enabling efforts The proposed studies should be empirical in nature, product driven, and focused on the accumulation of data to support an IND application to the U.S. Food and Drug Administration. Applicants are required to identify lead BMF therapy candidate(s), and transition plans should be considered and adequately described. At least one, and no more than three, lead therapeutic candidates must be named at the time of application submission to meet the intent of the FL2 mechanism. • Emphasis on research approach and impact. • Strong BMF research team. • Preliminary data required. • Clinical trials are not allowed. • Must address at least one of the FY23 BMFRP Focus Areas. • Partnering Principal Investigator (PI) Option: Allows two PIs, termed Initiating and Partner. The maximum allowable funding for the entire period of performance is $675,000 for direct costs (plus indirect costs).
• Rare Cancers Research Program (RCRP): Idea Development Award (IDA)
  Pre-Application (Letter of Intent): June 23, 2023 at 5:00 p.m. Eastern Time (ET); Application Deadline: September 29, 2023
  Supports new ideas that are still in the early stages of development and have the potential to yield impactful data and new avenues of investigation. • Supports research supported by preliminary data that could lead to critical discoveries or major advancements that will accelerate progress toward eradicating deaths and suffering from rare cancers. The maximum allowable funding for the entire period of performance is $350,000 for direct costs.
• Rare Cancers Research Program (RCRP): Resource and Community Development Award (RCDA)
  Pre-Application (Letter of Intent): June 23, 2023 at 5:00 p.m. Eastern Time (ET); Application Deadline: September 29, 2023
  Supports development of research platforms to share resources, knowledge, and information to facilitate collaboration among stakeholders such as researchers, patients, caregivers, clinicians, and other members of the rare cancers’ community. • Supports platform development or infrastructure that can be applied to multiple rare cancers. • Applications to the RCDA funding opportunity are required to include patient advocates who are involved with patient advocacy organization(s). The research team must include at least two rare cancer patient advocates as early and integral partners throughout the planning and implementation of the research project, including development of the research question, project design, oversight, and evaluation. • Preliminary data are not required but may be included (translational research and clinical studies may be included). • Submission must address the FY23 Platform Development Focus Areas. The maximum allowable funding for the entire period of performance is $800,000 for direct costs.
• Rare Cancers Research Program (RCRP): Concept Award (CA)
  Pre-Application (Letter of Intent): July 14, 2023 at 5:00 p.m. Eastern Time (ET); Application Deadline: August 25, 2023
  Supports highly innovative, untested, potentially groundbreaking novel concepts in rare cancers. • Supports high-risk studies that have the potential to reveal entirely new avenues for investigation. Applications must describe how the new idea will enhance the existing knowledge of rare cancers or develop an innovative and novel course of investigation • Submission must address at least one of the FY23 Focus Areas. The maximum allowable funding for the entire period of performance is $100,000 for direct costs.
• Vision Research Program (VRP): Clinical Trial Award (CTA)
  Pre-Application (Letter of Intent): July 14, 2023 5:00 p.m. ET; Application Deadline: November 8, 2023
  Supports the rapid implementation of early-phase clinical trials (i.e., phase 0 through phase 2a) of new interventions to service-connected eye injury and visual dysfunction. The maximum allowable funding for the entire period of performance is $1,600,000 for direct costs (plus indirect costs).
• Vision Research Program (VRP): Focused Translational Team Science Award (FTTSA)
  Pre-Application (Letter of Intent): July 14, 2023 5:00 p.m. ET; Application Deadline: November 8, 2023
  Supports a team initiative that leverages the strengths of investigators specializing in different fields to address an overarching scientific challenge or question and fundamentally advance the understanding and treatment of military-relevant vision trauma/dysfunction. The maximum allowable funding for the entire period of performance is $4,000,000 for direct costs (plus indirect costs).
• Vision Research Program (VRP): Investigator-Initiated Research Award (IIRA)
  Pre-Application (Letter of Intent): July 14, 2023 5:00 p.m. ET; Application Deadline: November 8, 2023
  Supports studies that will yield highly impactful discoveries or major advancements in research and/or patient care. The maximum allowable funding for the entire period of performance is $260,000 for direct costs (plus indirect costs).
• Vision Research Program (VRP): Translational Research Award (TRA)
  Pre-Application (Letter of Intent): July 14, 2023 5:00 p.m. ET; Application Deadline: November 8, 2023
  Supports translational research that moves promising laboratory research into clinical applications. The maximum allowable funding for the entire period of performance is $1,000,000 for direct costs (plus indirect costs).
• Neurofibromatosis Research Program (NFRP)
  Pre-Application (Preproposal): August 11, 2023; Application Due: August 25, 2023
  Includes the Neurofibromatosis Research Academy-Leadership Award (New for FY23), Clinical Trial Award, Early Investigator Research Award, Exploration – Hypothesis Development Award, Investigator – Initiated Research Award, New Investigator Award, and Synergistic Idea Award.
• Hearing Restoration Research Program (HRRP): Focused Research Award (FRA)
  Pre-Application (Letter of Intent): August 15, 2023 5:00 p.m. ET; Application Deadline: September 1, 2023
  Research must address one or more of the FY23 HRRP Focus Areas. • Funding Level 1 supports exploratory, highrisk/high-reward research that is in the earliest stages of idea development. • Funding Level 2 supports the advancement of more mature research toward clinical translation. • Funding Level 3 supports research with a translational research component and a related pilot clinical trial component. • It is the responsibility of the applicant to select the funding level that is most appropriate for the research proposed. The funding level should be selected based on the stage and maturity of the research, rather than the amount of the budget. • Tinnitus or vestibular-related research is excluded.
• NYS Department of Health Office of Minority Health and Health Disparities Prevention: Mentorship in Medicine and Other Healthcare Professions RFAs
  Application Due: August 31, 2023 at 4 PM ET
  The New York State Department of Health (NYSDOH), Office of Minority Health and
  Health Disparities Prevention (OMH-HDP), announces the availability of funds to support its Mentorship in Medicine and Other Health Professions Initiative 2024-2029. The purpose of this funding is to support activities and approaches designed to contribute toward the reduction of barriers by promoting an increase in the number of economically disadvantaged and underrepresented minority students who elect to pursue careers in medicine and health related professions to become physicians and other health care professionals. It is anticipated that approximately $250,000 will be available to support one (1) award of up $50,000 per year for five years.
• Cancer Research Institute Irvington Postdoctoral Fellowship, the Postdoctoral Fellowship to Promote Racial Diversity, and the CRI Immuno-Informatics Postdoctoral Fellowship
  Application Deadline: September 1, 2023
  All CRI Fellows receive $228,000 over three years plus $15,000 in institutional allowance and additional support for fellows to attend CRI’s 10 annual International Cancer Immunotherapy Conference (CICON) and its NEW Bioinformatics Bootcamp. Additional opportunities for mentoring are offered to fellows supported by the Diversity Fellowship.
• Crohn & Colitis Foundation Funding for IBD Produce Development
  Letter of Intent Due: September 4, 2023
  Are you seeking funding for the development of a product intended to address unmet needs of IBD patients? Apply to the Crohn’s & Colitis Foundation’s IBD Ventures program. Up to $500,000 of funding can be requested, as well as potential access to IBD Plexus®, the
  Foundation’s transformative IBD research platform. Companies, academic institutions, and research organizations can apply.
• Leducq Foundation International Networks of Excellence Program
  Letter of Intent Due: September 6, 2023
  The Leducq Foundation announces a call for applications typically in June of each year. The International Networks of Excellence Program award is $8,000,000 over five years. The INE program is open to investigators worldwide. Network coordinators must be from different continents. All Leducq networks should demonstrate the added value of international collaboration for their research program.
• American Heart Association: AHA Predoctoral Fellowship
  Application Deadline: September 6, 2023
  Enhances the training of promising students in pre-doctoral or clinical health professional degree training programs and who intend careers as scientists, physician-scientists or other clinician-scientists, or related careers aimed at improving global health and wellbeing.
• American Heart Association: AHA Postdoctoral Fellowship
  Application Deadline: September 7, 2023
  Enhances the training of postdoctoral applicants who are not yet independent. The applicant must be embedded in an appropriate investigative group with the mentorship, support, and relevant scientific guidance of a research mentor.
• American Heart Association: Institutional Award for Undergraduate Student Training
  Application Deadline: September 13, 2023
  This award is made to qualified institutions that can offer meaningful research experience that supports the AHA mission that encourages undergraduate college students from all disciplines to consider research careers.
• American Heart Association: AHA Institutional Research Enhancement Award (AIREA)
  Application Due: September 14, 2023
  Stimulates research at educational institutions that provide baccalaureate or advanced degrees related to scientific research training. Eligible institutions may not have been major recipients of NIH support. Awards provide funding for small-scale research projects related to cardiovascular diseases and brain health, enhancing the research environment at eligible institutions, and exposing students to research opportunities.
• Simons Foundation Autism Research Initiative (SFARI) Summer Pilot Award
  Application Deadline: September 14, 2023
  The goal of the Pilot Award is to provide early support for exploratory ideas, particularly those with novel hypotheses for autism. Appropriate projects for this funding mechanism include those considered higher risk but with the potential for transformative results.
• Pancreatic Cancer Research Program (PCARP): Focused Pilot Award (New)
  Pre-Application (Preproposal): September 14, 2023; Application Due: October 5, 2023
• The ALS Association Clinical Research Scholarships
  Application Deadline: September 14, 2023
  Clinical Research Training Scholarship in ALS (co-funded by The ALS Association and American Brain Foundation in collaboration with the American Academy of Neurology); Richard Olney Clinician-Scientist Development Award (co-funded by The ALS Association and American Brain Foundation in collaboration with the American Academy of Neurology); Clinical Research Training Scholarship in ALS and Related Disorders (co-funded by the CReATe Consortium and American Brain Foundation in collaboration with the American Academy of Neurology).
• FY23 Kidney Cancer Research Program (KCRP): Academy of Kidney Cancer Investigators Early-Career Scholar Award (AKCIECSA)
  Pre-Application (Preproposal): September 15, 2023 5:00 p.m. Eastern Time; Application: October 6, 2023 11:59 p.m. Eastern Time
  Investigators within 4 years of last postdoctoral research position (Ph.D.) or clinical fellowship (M.D.), or equivalent, as of full application submission deadline. Supports addition of new Early-Career Scholars (ECS) to the unique, interactive virtual academy, which provides intensive mentoring, national. The maximum allowable funding for the entire period of performance is $725,000 for direct costs.
• FY23 Kidney Cancer Research Program (KCRP): Clinical Trial Award (CTA)
  Pre-Application (Preproposal): September 15, 2023 5:00 p.m. Eastern Time; Application: October 6, 2023 11:59 p.m. Eastern Time
  Independent investigators at all levels. Supports hypothesis-based, early-phase clinical trials (e.g., phase 0, phase 1, pilot phase 2) to test interventions that will have a major impact in the field of kidney cancer. The maximum allowable funding for the entire period of performance is $1,500,000 for direct costs.
• FY23 Kidney Cancer Research Program (KCRP): Idea Development Award (IDA)
  Pre-Application (Preproposal): September 15, 2023 5:00 p.m. Eastern Time; Application: October 6, 2023 11:59 p.m. Eastern Time
  Investigators at or above the level of Assistant Professor (or equivalent). Supports new ideas that represent innovative, high-risk/high-gain approaches to kidney cancer research and have the potential to make an important contribution to kidney cancer. The maximum allowable funding for the entire period of performance is $800,000 for direct costs.
• FY23 Kidney Cancer Research Program (KCRP): Nurse-Initiated Research Award (NIRA)
  Pre-Application (Preproposal): September 15, 2023 5:00 p.m. Eastern Time; Application: October 6, 2023 11:59 p.m. Eastern Time
  As of full application submission deadline, investigators: Must be licensed registered nurse and/or Have a terminal degree of DNP or PhD in Nursing (or equivalent). Supports innovative, high-impact kidney cancer research, conducted by nurses working in clinical practice and/or an academic environment (DNP or PhD), to advance ideas or clinical care. The maximum allowable funding for the entire period of performance is $300,000 for direct costs.
• FY23 Kidney Cancer Research Program (KCRP): Translational Research Partnership Award (TRPA)
  Pre-Application (Preproposal): September 15, 2023 5:00 p.m. Eastern Time; Application: October 6, 2023 11:59 p.m. Eastern Time
  Investigators at or above the level of Assistant Professor (or equivalent). One partner must have experience in kidney cancer or kidney cancer patient care. This award supports the development of translational research collaborations between two independent, faculty-level investigators to address a central problem or question in kidney cancer in a manner that would be less readily achievable through separate efforts. The maximum allowable funding for the entire period of performance is $750,000 for direct costs.
• Melanoma Research Alliance Funding Opportunities
  Application Deadlines:
  September 20, 2023: Letters of Intent (LOI) for Team Science Awards due
  October 20, 2023: Eligibility Checklist for Young Investigator & Dermatology Career Development Award applicants due
  November 3, 2023: Proposals for individual investigator awards due
  January 4, 2024: Invited Team Science Award full proposals due
  The Melanoma Research Alliance (MRA) is pleased to announce a Request for Proposals (RFP) for pre-clinical, translational, and early clinical research with the potential to produce unusually high impact, near-term advancements in melanoma prevention, detection, diagnosis, and treatment. This cycle, proposals will be accepted for Team Science Awards, Academic-Industry Partnership Award (for Team Science Awards), Young Investigator Awards, Pilot Awards, and Dermatology Career Development Awards.
• Department of Defense RFI Biological Sequencing and in Field Sample Preparation
  Application Deadline: September 21, 2023
  PM CBRN SOF has posted a Request For Information (RFI) for Biological Sequencing and in field Sample Preparation on SAM.gov
• International Center for Responsible Gaming Grant Support for Research on Online Gambling and Potential Harms
  Application Deadline: Sept. 29, 2023
  Up to $172,500 Available for a Two-Year Grant
  The International Center for Responsible Gaming (ICRG) invites investigators to apply for a grant to study online gambling, and potential health harms, in the US.Applicants may request up to a total of $75,000 per year for up to two years plus 15 percent in Facilities & Administration costs. The ICRG will support one grant award under this initiative, which was made possible by support from the Boyd Gaming Corporation.
• Biocodex Microbiota Foundation
  Application Deadline: October 1, 2023
  The total grant amount is $50,000 USD
  With a mission of advancing the research and understanding of human microbiota, the Biocodex Microbiota Foundation is calling on inspired early career researchers from American institutions in the microbiome field to submit proposals for funding their projects. Leveraging a national board of independent scientists to select the most exciting proposal and to help fund young investigators, Biocodex plans to lead the charge in this field of study by giving an annual national grant to different research topics in the microbiome field.
• American Heart Association: Get With The Guidelines® Early Career Investigator Seed Grants
  Proposals due by October 16, 2023
  These grants serve as steppingstones to future opportunities in research, collaboration, and scientific advancement. Recipients will receive AHA/ASA national level oversight, valuable Get With The Guidelines Committee leadership, and mentorship from key volunteer physicians. One early career grant will be awarded per module (Atrial Fibrillation, Coronary Artery Disease, Heart Failure, Resuscitation, and Stroke).
• American Cancer Society Updates to Grant Mechanisms
  Application Deadline: October 16, 2023
  The American Cancer Society is excited to announce new updates to a number of grant mechanisms to support beginning investigators, clinician scientists, postdoctoral fellows, as well as independent investigators at any career stage.
• FY23 Kidney Cancer Research Program (KCRP): Clinical Consortium Award (CCA)
  Pre-Application (Preproposal): October 26, 2023 5:00 p.m. Eastern Time; Application: November 9, 2023 11:59 p.m. Eastern Time
  The Coordinating Center and each Clinical Research Site Principal Investigator must be an independent investigator with a faculty-level appointment (or equivalent). Supports a consortium to facilitate the rapid execution of collaborative phase 1 and 2 clinical trials that will bring to market high-impact, novel therapeutics that will ultimately and significantly decrease the impact of kidney cancer. The maximum allowable funding for the entire period of performance is $6,000,000 for direct costs.
• American Heart Association: Career Development Award
  Application Due: December 6, 2023
  Supports highly promising healthcare and academic professionals in the early years of first professional appointment to assure the applicant’s future success as a research scientist in the field of cardiovascular and/or cerebrovascular disease research.
• Crohn’s & Colitis Foundation – IBD Plexus Academic Request for Proposals
  Rolling Submission
  The goal of IBD Plexus is to accelerate research in high impact areas. The Foundation seeks research proposals that would utilize IBD Plexus biosamples and / or data to drive progress towards precision medicine and / or leverage real world data to produce real world evidence.
• NSF-BSF Program in Computer Networks and Systems
  Rolling Submission
  The U.S.-Israel Binational Science Foundation (BSF) is accepting applications in a joint funding program with the Division of Computer and Network Systems (CNS), in the Directorate for Computer and Information Science and Engineering (CISE) of the U.S. National Science Foundation (NSF).
• NSF-BSF PROGRAM IN Foundational Research in Robotics
  Rolling Submission
  The U.S. – Israel Binational Science Foundation (BSF) is accepting applications in joint funding programs in Foundational Research in Robotics, with the Computer and Information Science and Engineering (CISE); Engineering (ENG) Directorates of the U.S. National Science Foundation (NSF).
• Tourettes Association: Research Consortia and Collaborative Research Projects
  Rolling Submission
  TAA has historically provided critical seed funding to research consortia working on large issues relevant to TS, including the TAA genetics consortium, neuroimaging consortium, behavioral sciences consortium, deep brain stimulation registry and Treating Tourette Together summit. TAA aims to continue supporting research efforts like these, that crossover different scientific and medical disciplines and that encourage collaboration among researchers and institutions.

Development Office’s Corporate and Foundation (C&F)

The Development Office’s Corporate and Foundation (C&F) Team identified the below funding opportunities. To apply, please contact DevCorpFound@mountsinai.org. The C&F team will help plan, write, and submit your application.

• NY Health Foundation: 2024 Special Projects Fund
  Amount: Up to $300,000
  Deadline: LOI due September 12, 2023
  Eligibility:
  Project directly aligns with NYHealth’s mission, including improving the health of people of color and others who have been historically marginalized
  Project has an effective evaluation plan, including measures for local, regional, or statewide impact.
  Project builds collaboration among organizations and demonstrates meaningful community input and participation in the design and implementation.
  Project has a strong potential for replication elsewhere in New York State or nationally.
  Applicant articulates how the project will be financially and programmatically sustainable after onetime grant support from NYHealth (particularly relevant for projects that start new services).
  Applicant demonstrates how and why the initiative represents a special opportunity for NYHealth funding.
  Applicant demonstrates a degree of creativity or innovation.
  Projects Not Eligible for Funding:
  Projects that fall under any of our priority areas: Primary Care; Healthy Food, Healthy Lives; or Veterans’ Health.
  Projects that involve funding of ongoing services or activities similar to the normal activities undertaken by an organization.
  Requests for core support/organizational infrastructure. Core support includes baseline operating and administrative costs, board development, staff development unrelated to the project, recouping revenue losses, and fundraising activities.
  Projects that involve the purchase, installation, or upgrade of health information technology systems, including electronic medical records and other equipment.
  Projects that are biomedical research-oriented.
  Projects that focus on lobbying.
  Capital expenses (e.g., buildings, vehicles, rent).
  About: Supports implementation of projects that can improve health at the local, regional, or statewide levels. The most competitive applications are requests for projects and initiatives that have strong potential for replication, scaling, and/or implications for statewide policy and systems change.
• American Gastroenterological Association: Funderburg Research Award in Gastric Cancer
  Application Deadline: September 13, 2023
  Amount: $100,000 over 2 years
  Eligibility: Applicants must be established as an independent investigator in the field of gastric biology. MD applicants are considered “established” if seven or more years have elapsed following the completion of clinical training (GI fellowship or its equivalent) at the start date of this award (i.e., January 2023). PhD applicants are considered “established” if seven or more years have elapsed following the awarding of the PhD degree and the start date of this award (i.e., January 2023). Applicants for this award must hold an MD, PhD and/or equivalent degree (e.g., MBBS, MBChB, DO). Applicants must hold a full‐time faculty or equivalent position. AGA membership is required at the time of application submission. About: The objective of this AGA Research Foundation award is to support an established investigator in the field of gastric cancer research working to enhance our fundamental understanding of gastric cancer pathobiology or approaches to prevent, treat or cure gastric cancer.
• AGA-Caroline Craig Augustyn & Damian Augustyn Award in Digestive Cancer
  Application Deadline: September 13, 2023
  Amount: $40,000
  Eligibility: Applicants must hold an NIH K series (e.g., K01, K08, K23, K99, R00) or other federal or non-federal career development award of at least four years’ duration. There must be at least one year remaining on the award on Jan. 1, 2023. Applicants may not hold an R01 or equivalents such as a VA Merit award. Candidates for this award must hold an MD, PhD and/or equivalent degree (e.g., MB, ChB, MBBS, DO). Applicants must hold a full-time faculty or equivalent position. Applicants must classify as “early career” according to the following criteria: MD applicants are considered “early career” if no more than seven years have elapsed following the completion of clinical training (GI fellowship or its equivalent) at the start date of this award (i.e., January 2023). PhD applicants are considered “early career” if no more than seven years have elapsed following the awarding of the PhD degree and the start date of this award (i.e., January 2023). AGA membership is required at the time of application submission.
  About: The objective of this AGA Research Foundation award is to provide supplemental funding to early career investigators who have existing career development awards and are conducting research relevant to the pathogenesis, prevention, diagnosis or treatment of digestive cancer.
• American Gastroenterological Association: Pfizer Pilot Research Award in Non-Alcoholic Steatohepatitis
  Amount: $30,000 over 1 year
  Deadline: September 13, 2023
  Eligibility:
  Applicants for this award must hold an MD, PhD and/or equivalent degree (e.g., MBBS, MBChB, DO) and a full-time faculty position or equivalent at an institution in North America (U.S., Canada or Mexico).
  AGA membership is required at the time of application submission.
  Applicants performing any type of research (basic, translational, clinical) relevant to digestive disorders are eligible to apply.
  Application requirements
  The proposed research must focus on the pathophysiology, epidemiology, prevention, diagnosis, treatment or patient outcomes of NASH.
  Early career investigators are required to have a mentor for this award. The preceptor will supervise the principal investigator’s research activities ensuring timelines and deliverables.
  MD applicants are considered “early career” if no more than seven years have elapsed following the completion of clinical training (GI fellowship or its equivalent) at the start date (i.e., April 2024) of this award.
  PhD applicants are considered “early career” if no more than seven years have elapsed following the awarding of the PhD degree and the start date (i.e., April 2024) of this award.
  For all applicants at the instructor or assistant professor level, a letter of recommendation from their division chief or department chair that outlines support of the applicant and their research project is required.
  Established investigators who are applying for this award should state explicitly how the proposed research is different from their previous line(s) of investigation.
  The application must indicate how the principal investigator will use the pilot data as an extension of their work that will allow them to apply for additional funding through another agency, such as NIH.
  A completed research facilities and resources form must be submitted.
  Biographical sketches for the applicant, mentor (if applicable) and all key personnel must be submitted.
  A list of the applicant’s current and pending other support.
  Upon notification of receipt of this award, the recipient must provide approval from the appropriate institutional committee(s) for use of human subjects or animals. If approval is not necessary, the recipient must provide documentation from the appropriate regulatory committee.
  Recipients must submit scientific and financial progress reports to AGA upon completion of the award and as needed at the request of the AGA Research Foundation.
  Additional pre-award policies are available for reference.
  About: Provides funds for early career investigators to help establish their research careers or to support projects that represent new research directions for established investigators.
• American Academy of Neurology: Clinical Research Training Scholarship in ALS
  Deadline: September 14, 2023
  Amount: $150,000 over 2 years
  Eligibility: Recipient must be an AAN member interested in an academic career in neurological research who has completed residency or a PhD no more than 5 years prior to the beginning of this award (July 1, 2024). If you have completed both residency and a PhD, your eligibility is based on when you completed residency. If you completed a fellowship of any kind after residency, your eligibility is still based on the date you finished residency.
  About: This award aims to recognize the importance of good clinical research and to encourage early career investigators in clinical studies in ALS. For the purpose of this scholarship, research is defined as “patient-oriented research conducted with human participants, or translational research specifically designed to develop treatments or enhance diagnosis of neurologic disease. These areas of research include epidemiologic or behavioral studies, clinical trials, studies of disease mechanisms, the development of new technologies, and health services and outcomes research.” Disease-related studies not directly involving humans or human tissue are also encouraged if the primary goal is the development of therapies, diagnostic tests, or other tools to prevent or mitigate neurological diseases.
• Career Development Award
  Deadline: September 14, 2023
  Amount: $450,000 over 3 years
  Eligibility: Recipients of individual K or R awards are not eligible to apply for the Career Development Award (CDA). Applicants are allowed to apply for the AAN CDA and other federally funded career development awards (including NIH K awards and VA CDAs) or other career development awards supported by foundations of a similar scope simultaneously.
  About: The American Academy of Neurology is pleased to announce a three-year award to support junior investigators interested in an academic career in neurology.
• Richard Olney Clinician Scientist Development Award in ALS
  Deadline: September 14, 2023
  Amount: $240,000 over 3 years
  Eligibility: Recipient must be an AAN member interested in an academic career in neurological research who has completed residency or a PhD no more than 7 years prior to the beginning of this award (July 1, 2024). If you have completed both residency and a PhD, your eligibility is based on when you completed residency. If you completed a fellowship of any kind after residency, your eligibility is still based on the date you finished residency.
  About: This award recognizes the importance of good clinical research and encourages early career investigators in clinical studies in ALS.
• Neuroscience Research Training Scholarship
  Deadline: September 14, 2023
  Amount: $150,000 over 2 years
  Eligibility: Recipient must be an AAN member interested in an academic career in neurological research who has completed residency or a PhD no more than 5 years prior to the beginning of this award (July 1, 2024). If you have completed both residency and a PhD, your eligibility is based on when you completed residency. If you completed a fellowship of any kind after residency, your eligibility is still based on the date you finished residency.
  About: The award aims to recognize the importance of and encourage young investigators in, good laboratory or preclinical research.
• Practice Research Training Scholarship
  Deadline: September 14, 2023
  Amount: $150,000 over 2 years
  Eligibility: Recipient must be an AAN member interested in an academic career in neurological research who has completed residency or a PhD no more than 5 years prior to the beginning of this award (July 1, 2024). If you have completed both residency and a PhD, your eligibility is based on when you completed residency. If you completed a fellowship of any kind after residency, your eligibility is still based on the date you finished residency.
  About: to support practice-based research, which is defined as “clinical research that evaluates translation of evidence into best clinical practice.” This may include evaluation of health services, quality of care, implementation of therapies, physician performance, or patient adherence. It is intended to create unique training opportunities previously difficult to access for neurologists. This award aims to recognize the importance of good practice-based research or comparative effectiveness research (CER) and encourage young investigators to use studies to improve health systems and services.
• SONY Focused Research Award
  Amount: $150,000 over 1 year
  Deadline: September 15, 2023
  Eligibility: Principal Investigators (PIs) must meet the eligibility criteria below:
  PI’s institution: PIs must belong to a university, educational institution, or governmental/non-profit research institute. (E.g., we accept submissions from research institutes that are categorized as governmental and NPO/NGO in nature index tables.)
  PI’s position: PIs must be a full-time professor (adjunct professors and adjunct researchers are not eligible) or researcher and be eligible to supervise Ph.D. students at the PI’s institution. Full professors, associate professors, and assistant professors are eligible to apply. For the UK, this includes Senior Lecturers, Principal Lecturers, Lecturers, and Readers who are eligible to supervise Ph.D. students at their institutions.
  Countries: The PI’s institution must be in Austria, Belgium, Canada, Denmark, Finland, France, Germany, India, Ireland, Italy, Luxembourg, the Netherlands, Norway, Poland, Portugal, Spain, Sweden, Switzerland, the United Kingdom, and the United States of America.
• SONY Faculty Innovation Award
  Amount: $100,000 over 1 year
  Deadline: September 15, 2023
  Eligibility:
  PI’s institution: PIs must belong to a university, educational institution, or governmental/non-profit research institute. (E.g., we accept submissions from research institutes that are categorized as governmental and NPO/NGO in nature index tables.)
  PI’s position: PIs must be a full-time professor (adjunct professors and adjunct researchers are not eligible) or researcher and be eligible to supervise Ph.D. students at the PI’s institution. Full professors, associate professors, and assistant professors are eligible to apply. For the UK, this includes Senior Lecturers, Principal Lecturers, Lecturers, and Readers who are eligible to supervise Ph.D. students at their institutions.
  Countries: The PI’s institution must be in Austria, Belgium, Canada, Denmark, Finland, France, Germany, India, Ireland, Italy, Luxembourg, the Netherlands, Norway, Poland, Portugal, Spain, Sweden, Switzerland, the United Kingdom, and the United States of America.
• ChadTough Foundation: Fellowship
  Deadline: September 15, 2023
  Amount: $200,000 over 2 years for pre-doctoral fellows and $300,000 over 3 years for postdoctoral fellows
  About: Awarded to outstanding pre-doctoral and post-doctoral fellows under the guidance of a mentor to help develop the next generation of leaders in DIPG research.
• Hyde Watson Foundation
  Deadline: September 15, 2023
  Amount: $20,000
  About: The Foundation supports capital projects such as hard costs related to the construction or purchase of new facilities, building renovations and improvements, purchase of capital equipment and furnishings, and other one-time capital needs. (Computer software that is subscription-based or has recurring fees is not considered a capital expense.
• National Ataxia Foundation: Research Seed Money Grant
  Amount: $50,000 over 1 year
  Deadline: LOI due September 15, 2023
  Eligibility:
  Faculty member or senior scientist at a research institution.
  Non-U.S. citizens are eligible to apply for a NAF grant award. Grant applications are accepted from U.S. and international institutions.
  Awards are not transferable to other researchers, but subject to NAF approval, may be transferred to a new institution should the awardee change institutions.
  All awardees must agree to ResearchFish Statement
  About: Supports new and innovative studies that are relevant to the cause, pathogenesis or treatment of the hereditary or sporadic ataxias.
• J.W. Couch Foundation: Wellness Grant
  Amount: Up to $275,000
  Deadline: September 15, 2023
  Eligibility: Must be a registered 501(c)3 non-profit organization or a for-profit organization that is aligned with one of our three charitable programs: preservation, education, or wellness.
  About: We are looking for teams that are helping those who struggle with mental health issues such as depression, anxiety, bi-polar, schizophrenia, PTSD.
• Greenwall Foundation: Faculty Scholars Program in Bioethics
  Amount: 50% of salary (+10% fringe) over 3 years
  Deadline: LOI due September 18, 2023
  Eligibility:
  Applicants must be junior faculty members at a university or non-profit research institute that has tax-exempt status in the United States.
  Applicants must hold a faculty appointment (or other long-term research position outside a university) that allows at least 50 percent of their effort to perform research (often this is a faculty position with at least a 60 percent appointment in a tenure-track position or its equivalent).
  Priority will be given to applicants who have not yet been considered for tenure or an equivalent promotion;
  whose research will have an impact on clinical, biomedical, and public health decision-making, policy, and practice;
  and who will make important contributions to the field of bioethics over their careers.
  Only one applicant from a university or non-profit research institute will be considered in each application cycle. Institutions should have an internal screening and selection process, as the Foundation will not consider multiple letters of intent received from a single institution. For purposes of this limitation, the Foundation considered the overseeing university to be the institution. Thus, a university with a law school, medical school, several teaching hospitals, and a faculty of arts and sciences may only submit one application in total. If a university system, such as a state-wide university system, comprises several universities, each university within the system may nominate one applicant.
  About: Career development award to enable junior faculty members to carry out innovative bioethics research. It supports research that goes beyond current work in bioethics to help resolve pressing ethical issues in clinical, biomedical, and public health decision-making, policy, and practice, and creates a community that enhances future bioethics research by Scholars and Alumni/ae.
• Melanoma Research Alliance: Team Science Academic-industry Partnership Award
  Amount: Up to $900,000 over 3 years
  Deadline: LOI due September 20, 2023
  Eligibility:
  Team must be multidisciplinary, and consist of two or more established Principal Investigators, one of whom is designated the Administrative PI, a Young Investigator with complementary expertise, and a Mentor for the Young Investigator;
  All Young Investigators on Team Science Award applications must complete the Applicant Eligibility Checklist and upload it as an attachment with the LOI.
  An investigator may only be the designated Young Investigator on one application in the Team Science Award category. However, a Young Investigator identified within a Team Science Award application may also apply in the same cycle for their own, individual Young Investigator Award provided that application has a unique research focus and hypothesis.
  Teams may consist of investigators from the same institution, or different institutions, and may be international;
  The designated Administrative PI is responsible for administrative leadership. All other Principal Investigators on the team share authority for scientific leadership;
  The Administrative PI and any other Principal Investigators on the team must be senior investigators, past the initial five years of their first academic faculty appointment and must hold a full-time faculty appointment at the level of Assistant Professor (or equivalent) or above. Co-PIs are not allowed. Other investigators on the team need to be designated as Co-Investigators, Collaborators, or Consultants. See Step #6 under the Application Instructions below for additional details and descriptions of these roles;
  An investigator may serve as a PI, including Administrative PI or Principal Investigator on a Team, on only one proposal this cycle.
  Applicants must identify an industry partner at the time of application.
  Industry scientists may serve as Co-investigators or Collaborators, but may not be PIs.
  About: Designed to enhance translational research by extending academic capabilities to clinical investigations and to facilitate interactions between the academic and industrial research sectors.
• Cystic Fibrosis Foundation: Clinical Research Award
  Amount:
  For multi-center studies, up to $1,050,000 over 3 years
  For single-center studies, up to $450,00 over 3 years
  Deadline: LOI due September 21, 2023
  Eligibility:
  United States residents and applicants from outside the United States are welcome to apply.
  International applicants and institutions are required to submit additional information in accordance with USA Patriot Act and the U.S. Department of Treasury Anti-Terrorist Financing Guidelines (see section VI.10.L below). 2024 CFF Clinical Research Award Policies and Guidelines
  Applicants must be independent investigators. An independent investigator is an individual who is out of fellowship training and whose institution allows them to submit applications for research funding as a Principal Investigator.
  New or established investigators with no previous work in cystic fibrosis research who wish to apply their expertise to a problem in this area.
  Candidates who are clinical fellows should apply to the CFF Clinical Fellowship program for the appropriate year.
  Candidates who are postdoctoral fellows should apply to the CFF Postdoctoral Research Fellowship program.
  Industry-sponsored research projects are not eligible to apply through this program and instead should consider applying to the Therapeutics Development Awards program.
  About: Supports investigator initiated clinical research projects that have the potential to make an important contribution to the CF Foundation’s mission and address diagnosis, treatment, management of disease or symptom, or the pathophysiology of CF using clinical (observational/interventional), translational or epidemiologic study approaches.
• Target ALS: Early-Stage ALS Clinicians
  Amount: Up to $450,000 over 3 years
  Deadline: September 28, 2023
  Eligibility: To be eligible for this grant, applicants should:
  Be an early-stage ALS clinician or clinician scientist who received their clinical appointment on or after August 14, 2018.
  Commit to being clinically active during and after the award. During the award, 20-40% of their time should be spent caring for ALS patients.
  Hold an M.D. or equivalent degree (e.g. M.B.B.S. or M.B.B.Ch.).
  Each investigator can apply for only one project through this funding opportunity. If an investigator is already a recipient of another Target ALS grant, it is crucial to draw a clear distinction from the currently funded project
  About: This grant supports talented clinicians to pursue academic research in addition to their clinical practice, with the goal of making long-term improvements in the healthcare of ALS patients.
• Pharma Foundation: Empowering Health Care Equity: Harnessing Digital Health Tools for Inclusive Regulatory Decision-Making
  Amount: $25,000 for planning grant (if awarded eligible to apply for additional $500k over 3 years)
  Deadline: LOI due September 29, 2023
  Eligibility:
  Eligible applicants (U.S. and non-U.S. citizens) must be employed full time at an accredited U.S. university or research institution.
  Applicants must be eligible to apply for independent external research funding from their institution.
  About: Supports research on the use of digital health technologies in underrepresented populations in clinical trials to advance FDA regulatory decision-making.
• Alpha-1 Foundation: Pilot and Feasibility Grants
  Amount: Up to $75,000 over 1 year
  Deadline: LOI due September 29, 2023
  Eligibility: Proposed work must be hypothesis generating or hypothesis testing, reflecting innovative approaches to important questions in AAT research or development of novel methods, and providing sufficient preliminary data to justify the Foundation’s support. Results from Pilot and Feasibility Grants should lead to the submission of applications for funding from other agencies (i.e. NIH). At the conclusion of the funding term, applicants are expected to apply for further funding by other mechanisms or from outside agencies. The award is not intended to support continuation of programs begun under other granting mechanisms.
  About: Provides funds to encourage the development and testing of new hypotheses and/or new methods in research areas relevant to AAT Deficiency.
• Alpha-1 Foundation: Postdoctoral Research Fellowship Grants
  Amount: Up to $150,000 over 2 years
  Deadline: LOI due September 29, 2023
  Eligibility: Applications will be accepted from candidates holding an M.D., Ph.D. or equivalent degrees who are interested in conducting basic science, clinical research, or ethic, legal, social issues studies related to AAT Deficiency. Applicants must indicate a commitment to AAT-related research by focusing 50% of their time to AAT Deficiency research or clinical practice.
  About: Provides support for postdoctoral research fellows who are starting their research careers and are working in the laboratories of established researchers or conducting research with the mentorship of established researchers. In addition, this grant category is intended to provide support for postdoctoral research fellows who intend to pursue a career in AAT research.
• Alpha-1 Foundation: Research Grants
  Amount: Up to $200,000 over 2 years
  Deadline: LOI due September 29, 2023
  Eligibility: Consideration will be given to those projects that provide insight into the development of information that may contribute to new therapies for AAT Deficiency. All proposals must be hypothesis generating or hypothesis testing and provide sufficient preliminary data to justify the Alpha-1 Foundation’s support.
  About: Provide funds to encourage the development of new information that contributes to the understanding of the basic biology of alpha-1 antitrypsin expression, and the pathogenesis/management of AAT Deficiency. In addition, consideration will be given to those projects that provide insight into the development of information that may contribute to new therapies for AAT Deficiency.
• Alpha-1 Foundation: John W. Walsh Career Development Grant
  Amount: Up to $300,000 over 3 years
  Deadline: LOI due September 29, 2023
  Eligibility:
  Eligible candidates for this award must have a clinical doctorate (including M.D., D.O., or equivalent) and must be practicing physicians.
  No more than 6 years may have elapsed since the first faculty appointment at the assistant professor level or equivalent (including instructor, research assistant professor, research scientist, staff scientist, etc) at the time of the award. Interruptions of work experience due to extenuating circumstances will be considered on a case-by-case basis.
  A minimum of 70% of the applicant’s time must be devoted to research. Exceptions to this rule can be made at the discretion of the Alpha-1 Foundation and require consultation in advance.
  At the time of this award, the candidate must have a “full-time” faculty appointment at the applicant institution.
  Applicants who have already received an NIH K award (or equivalent career development award) or R-level grant award are not eligible to apply.
  About: Facilitates the establishment of a career in biomedical research for physician-scientists, is intended to continue his/her commitment to a cure through investment in the careers of junior physicians engaged in Alpha-1 research.
• Association for Research in Vision and Ophthalmology: Dr. David L. Epstein Award
  Amount: Up to $100,000 over 2 years
  Deadline: October 1, 2023
  Eligibility:
  Applicant must be the PI of an active research program and have a history of obtaining at least two NIH grants in the U or R series (or two grant equivalents if the applicant is from outside the United States), at least one of which is current.
  Applicant must have a record of accomplishment in successfully mentoring clinician-scientists to independent academic and research careers.
  Applicant must agree at time of application that Epstein Award funds will be used specifically to support a clinician-scientist, within five years of completion of formal training, in the awardee’s laboratory or area of research to further research for:
  a period of two years at a minimum of 30% effort per year. If funds remain at the end of two years, the principal investigator may apply for a no cost extension; OR
  one year at a minimum of 75% effort. If funds remain at the end of a year, the principal investigator may apply for a no cost extension.
  The applicant’s mentee must be committed to becoming a clinician-scientist; the mentee must have an MD or OD degree (or equivalent)
  Applicant must be an employee of a tax-exempt academic institution, and said institution must be willing to receive and disburse the award monies under the guidelines of ARVO. It is the responsibility of the applicant to ensure his/her institution can and will accept the award monies for the sole purpose set out in this award, as specified in the criteria, including that the institution agrees not to apply or withhold administrative fees or indirect costs.
  Must follow ARVO described processes for application including established deadlines.
  ARVO and ARVO Foundation Officers, Board members and ARVO Foundation Awards Committee members are not eligible to apply for or be nominated for an award nor may they supply letters of support during their term
  About: Supports solving the complex issues of glaucoma through well-conceived and executed scientific research focused on finding the causes and new treatments for glaucoma.
• Kavli Prize in Astrophysics, Nanoscience, Neuroscience
  Amount: $1,000,000
  Deadline: October 1, 2023
  About: The purpose of The Kavli Prize is to recognize outstanding scientific research, honor highly creative scientists, promote public understanding of scientists and their work, and foster international cooperation among scientists. In pursuit of honoring scientists whose research has fundamentally transformed these fields, we recognize and value that diverse perspectives enable breakthroughs, and we are committed to acknowledging breakthrough science from diverse scholars worldwide with regards to gender, race, ethnicity, geographical region and institutional diversity.
• Life Sciences Research Foundation Fellowship
  Amount: $231,000 over 3 years
  Deadline: October 1, 2023
  Eligibility: You must meet ALL of the following requirement to apply for an LSRF award.
  U.S. citizens are eligible to work in any geographic location. Non-U.S. citizens must work in a U.S. laboratory to be eligible for an award.
  Applicants must apply within 5 years of receiving their PhD (or MD/DVM whichever was awarded later) as of October 1, 2023. If you received your PhD (or MD/DVM) before October 1, 2018, you are not eligible to apply. You may apply before defending your thesis, but must have your PhD (or MD/DVM) degree by the time the award is activated on August 1st, 2024
  You must have begun (or will begin) working in your proposed postdoc lab between August 1, 2022 and July 31, 2024.
  The application requires a letter of acceptance from your proposed postdoctoral supervisor (the Principal Investigator of the lab where you will conduct your postdoctoral training).
  You must complete your postdoctoral training in a lab different from that of your graduate (thesis) lab. Applicants planning to remain in their thesis labs for the duration of their postdoctoral training period are NOT eligible. Remaining in your thesis lab for a few weeks or months after receiving your degree, before moving to your postdoc lab, is acceptable.
  About: LSRF administers an international program of postdoctoral fellowships in all areas of the life sciences: biochemistry; cell, developmental, molecular, plant, structural, organismic population and evolutionary biology; endocrinology; immunology; microbiology; neurobiology; physiology; virology.
• Whitehall Foundation Basic Biological Research Grants
  Amount: $150,000 over 2 years
  Deadline: LOI due October 1, 2023
  Eligibility: The applicant must meet all of the following eligibility requirements in order to participate in the application process:
  Appropriate title – must be an Assistant Professor (or higher). If the institution does not use this title, a letter from the department chair confirming the applicant’s eligibility is required.
  Status – must hold Principal Investigator status.
  Independent – must be considered an ‘independent investigator’ with their own dedicated lab space or with lab space independent of another investigator.
  The Foundation does not fund investigators who have substantial (approximately $200,000 per year) extramural funding. The Foundation uses the following formula to determine the PIs total extramural funding: Total direct per year plus total indirect per year less any PI salary taken from these grants. If this amount is greater than approximately $200,000 the PI would not be eligible for Whitehall Foundation funding. Startup funds and internal funding are not included in the calculation.
  About: The Foundation is currently interested in basic research in neurobiology, defined as follows: Invertebrate and vertebrate (excluding clinical) neurobiology, specifically investigations of neural mechanisms involved in sensory, motor, and other complex functions of the whole organism as these relate to behavior. The overall goal should be to better understand behavioral output or brain mechanisms of behavior.
• Genentech Career Development Award for Underrepresented Minority Emerging Vision Scientists
  Amount: Up to $100,000 over 2 years
  Deadline: October 1, 2023
  Eligibility:
  Applicant must be from historically disadvantaged backgrounds- e.g. membership in one or more of the following groups whose underrepresentation in the American Professoriate has been severe and longstanding:
  Alaskan Native (Aleut, Eskimo, or other indigenous People of Alaska)
  Black/African American/Afro-Caribbean
  Mexican/Mexican American
  Chicana/Chicano
  Latino/Latina
  Native American Indian
  Native Pacific Islander (Hawaiian/Polynesian/Micronesian)
  Puerto Rican
  Applicant must be within the first four (4) years of a primary academic appointment
  Applicant must have a strong record of scholarly productivity and be poised to become an independent investigator. Candidates with an active NIH R01 or equivalent government grant are not eligible. Candidates with a current or previous ARVO Foundation career development awards are also ineligible.
  Applicant must be employed in the United States. Applicants must be a US citizen, permanent resident, or have DACA status.
  Applicant must be working in the field of eye and/or vision research
  Applicant must have an academic appointment at the level of Instructor or Assistant Professor (or equivalent) at the time the award is made (December of the year of application)
  Applicant must not be related by blood or marriage to any current member of the awards committee, or any current officer of ARVO or the ARVO Foundation
  ARVO and ARVO Foundation Officers, Board members and ARVO Foundation Awards Committee members are not eligible to apply for or be nominated for an award nor may they supply letters of support during their terms
  About: Provides research funding to early-career underrepresented minority (URM) investigators who have received their initial faculty appointment and are working to establish an independent vision research program.
• American Roentgen Ray Society Scholarship
  Amount: $180,000 over 2 years
  Deadline: October 2, 2023
  Eligibility: Candidates must meet the following qualifications at the time of application:
  ARRS member at the time the application is submitted and for the duration of the award
  Earned MD or DO (or equivalent) from an accredited institution
  Completion of all required residency and fellowship training
  Hold a full-time faculty appointment as a lecturer, instructor, assistant professor, or equivalent for no more than five years beyond initial faculty appointment. The appointment must be in a department of radiology, nuclear medicine, or an associated department in the radiologic sciences of a medical school teaching hospital in the United States or Canada.
  Eligible for Certification by the American Board of Radiology or equivalent by the time of application
  Support from their Department Chair indicated in a letter of nomination with a commitment of an additional 20% protected time to complete the proposal submitted for the two-year program.
  Only one candidate per department per institution is eligible to be nominated each year.
  About: The ARRS Scholarship supports early-career faculty members in study/research in the radiologic sciences that has the possibility of changing the way radiology is practiced. The recognition and financial support aim to advance the early-career scholar professionally and to help prepare them for positions of leadership.
• The Mike Slive Foundation 2023-2024 Pilot Research Grant
  Amount: $50,000 over 1 year
  Deadline: October 02, 2023
  Eligibility: The following criteria will be considered when reviewing applications and directing funding decisions:
  Significance: Does the project address an important problem or a critical barrier to progress in the field? If the aims of the project are achieved, how will scientific knowledge, technical capability, and/or clinical practice be improved? How will successful completion of the aims change the concepts, methods, technologies, treatments, services, or preventative interventions that drive this field?
  Investigator(s): Are the PI(s), collaborators, and other researchers well suited to the project? If Early Stage Investigators or New Investigators, do they have appropriate experience and training? If established, have they demonstrated an ongoing record of accomplishments that have advanced their field(s)? If the project is collaborative or multi-PD/PI, do the investigators have complementary and integrated expertise; are their leadership approach, governance and organizational structure appropriate for the project?
  Innovation: Does the application challenge and seek to shift current research or clinical practice paradigms by utilizing novel theoretical concepts, approaches or methodologies, instrumentation, or interventions? Are the concepts, approaches or methodologies, instrumentation, or interventions novel to one field of research or novel in a broad sense? Is a refinement, improvement, or new application of theoretical concepts, approaches or methodologies, instrumentation, or interventions proposed?
  Approach: Is the overall strategy, methodology, and analyses well-reasoned and appropriate to accomplish the specific aims of the project? Are potential problems, alternative strategies, and benchmarks for success presented? If the project is in the early stages of development, will the strategy establish feasibility, and will particularly risky aspects be managed? If the project involves clinical research, are the plans for 1) protection of human subjects from research risks, and 2) inclusion of minorities and members of both sexes/genders, as well as the inclusion of children, justified in terms of the scientific goals and research strategy proposed?
  Environment: Will the scientific environment in which the work will be done contribute to the probability of success? Is the institutional support, equipment and other physical resources available to the investigators adequate for the project proposed? Will the project benefit from unique features of the scientific environment, subject populations, or collaborative arrangements?
  Scientific Review Criteria: As applicable for the project proposed, reviewers will consider the following additional items in the determination of scientific and technical merit but will not give separate scores for these items: Protections for Human Subjects; Inclusion of Women, Minorities, and Children; Vertebrate Animals; Biohazards; and Budget.
  About: Funds pilot grants for innovative research in an effort to allow researchers to establish proof-of-concept when applying for larger, highly competitive federal grants.
• Rheumatology Research Foundation: Innovative Research Award
  Amount: Up to $400,000 over 2 years
  Deadline: LOI due October 02, 2023
  Eligibility: To be eligible for this award, the applicant must:
  Be a member of the ACR or ARP at the time of submission and for the duration of the award,
  Hold a doctoral-level degree (MD, PhD, DO, DPT, MBBS or equivalent),
  Have a faculty appointment (professor, assistant professor, etc.) at an academic center or research institution at the time of application and for the duration of the award,
  Must exhibit evidence of research independence, scientific productivity and career accomplishments,
  Submit a suitable FTE percentage based on your reported support(s): Current, Other, and Pending. It is expected that PI effort will accurately reflect the time spent working on the project.
  The award allows for the option of a Co-PI. If a Co-PI is added to the application, all eligibility requirements must be met by the Co-PI. The PI and Co-PI must state their FTE and FTE percentages.
  Please Note:
  Principal Investigator(s) may not apply for more than one Foundation Innovative Research Award per cycle.
  Principal Investigator(s) may not hold two active Foundation grants simultaneously unless the grants are for two distinct purposes (ex. training award and Innovative Research Award).
  Two projects are not eligible for concurrent funding under the same mechanism (ex. Individual may not have two different Innovative Research Awards at the same time).
  The Foundation does not allow resubmission of grant applications. This means formal responses to the previous year’s critiques will not be accepted. Applicants may apply as many times as they wish; however, all grant applications will be reviewed as new applications.
  Scientific and/or budgetary overlap between Foundation grants and other funding sources (including NIH, VA, or other foundations) is not permitted.
  Individuals employed at the NIH, FDA or CDC are not eligible to apply.
  Investigators from outside the United States may serve as co-investigators with the PI who is based in the U.S. and who may sub-contract grant support to co- investigators.
  About: Provides independent academic investigators with the funding they need to pursue ideas that could lead to important breakthroughs in discovering new treatments and, one day, a cure. This award provides essential support for innovative studies focused on generating new insights into the cause, progression, treatment, and outcomes of rheumatic and musculoskeletal diseases.
• International Maternal Pediatric Adolescent AIDS Clinical Trials Network: Early Career Investigators Request for Proposals
  Amount: Up to $100,000 over 2 years
  Deadline: October 2, 2023
  Eligibility: Interested applicants must meet the following eligibility criteria:
  Affiliated with the IMPAACT Network.
  Holds a current master’s degree, doctoral degree, or MD (or local equivalent) and is within 10 years of graduation of their final degree or fellowship/training.
  Has experience either developing or participating in clinical research.
  Must identify a mentor who has been an investigator on an IMPAACT study and is ideally a current member of an IMPAACT Scientific Committee
  Proposed project uses data and/or specimens from one or more of the concluded IMPAACT studies listed on the IMPAACT website (https://www.impaactnetwork.org…). Projects proposing use of specimens obtained from non-IMPAACT studies will not be funded.
  Proposed project can reasonably be completed within the 2 year period.
  This program will only support investigations using existing data and/or stored specimens from completed IMPAACT clinical trials.
  This program is not intended to (1) develop a new clinical trial, (2) use data and specimens from ongoing studies, or (3) collect prospective data.
  About: Encourages early career investigators to propose a project that takes advantage of data and/or biological specimens generated by the IMPAACT Network.
• Focused Ultrasound Foundation and ALS Research Association: Request for Proposals
  Amount:
  If clinical project, up to $600,000 over 3 years
  If preclinical project, up to $200,000 over 2 years
  Deadline: October 2, 2023
  Eligibility:
  Applicants must hold a faculty appointment as a tenure-track assistant professor or higher rank at award activation.
  The project must be collaborative and require a team of at least one focused ultrasound researcher and one ALS expert.
  Priority will be given to the following research areas:
  Focused Ultrasound and Blood-Brain Barrier Opening (BBBO)
  Focused Ultrasound and Neuromodulation (NM)
  The following metrics must be captured:
  Biological: analyses of blood samples pre- and post-focused ultrasound as well as histopathological evaluation when necessary
  Acoustic: intensity/pressure (derated and non-derated), voltage/power/energy or whichever parameter used on the focused ultrasound device, pulsing parameters, sonication duration, frequency, and transducer characteristics, including diameter, focal depth, etc.
  Imaging: ultrasound, MR protocols (MR thermometry, acoustic radiation force impulse, shearwave imaging, elastography, functional MRI), or nuclear imaging used for treatment monitoring
  About: Supports the development of new focused ultrasound applications for the treatment and diagnosis of amyotrophic lateral sclerosis (ALS).
• Parker B. Francis Fellowship Program
  Amount: $225,000 over 3 years
  Deadline: October 10, 2023
  Eligibility: Applicants are eligible to apply for a PBF Fellowship if at the time of application they are:
  Scientists holding a relevant doctoral degree (e.g., M.D., Ph.D., Sc.D., D.V.M., Dr. P.H.) who are embarking on a career in clinical, laboratory or translational science related to Pulmonary, Critical Care and Sleep Medicine at a U.S. or Canadian university or research institution.
  A citizen or permanent resident of the U.S. or Canada or or holder of a Visa that spans the entire project period of the grant.
  A Ph.D. or other non-M.D. scientist no more than seven years beyond completion of their doctoral degree or an M.D. scientist no more than seven years beyond clinical training (i.e., residency, internship, clinical fellowship) at the time of application. Candidates with greater than seven years since the doctoral degree require approval for continued training from the Scientific Director of the PBF Fellowship Program.
  Applicants must be approved by their department to apply for the PBF Fellowship. Institutions may have no more than three Parker B. Francis Fellows in a single department at a given time, a department may submit no more than two applications annually, and a mentor may sponsor only one application annually.
  Individuals are not eligible for a PBF Fellowship if, at the time of application, they are or have been principal investigator on an NIH K or R series research award or other nationally competitive research award at the comparable level.
  If a PBF Fellow receives an NIH K or Research Award or any nationally competitive grant at a similar level, at any point on or after the start date of the PBF award, the amount of the award will be changed per the Allowable Cost policy. Please contact PBF@thoracic.org for more information.
  PBF Fellows are required to have at least 75 percent of their time available for research. Most successful candidates have two-to-five years of research experience and a minimum of two or three research publications at the time of fellowship application.
  About: The Parker B. Francis Fellowship provides research support to clinical and basic scientists embarking on careers in clinical, laboratory or translational science related to Pulmonary, Critical Care and Sleep Medicine at a U.S. or Canadian university or research institution.
• Pfizer Research Grant RFP Improving Health Equity in IBD through Disparities Research
  Amount: $250,000 over 2 years
  Deadline: October 11, 2023
  Eligibility:
  Only organizations are eligible to receive grants, not individuals or medical practice groups.
  The PI must have a medical or postdoctoral degree (MD, PhD, or equivalent), an advanced nursing degree (BSN with a MS/PhD), or a degree in Pharmacy, Physiotherapy, or Social Work.
  The applicant must be the PI or an authorized designee of such individual (e.g., PI’s research coordinator).
  The PI must be an employee or independent contractor of the requesting organization.
  Requesting organization must be legally able to receive award funding directly from Pfizer Inc. We strongly recommend that applicants confirm this with their organization or institution prior to submitting an application. Grants awarded to organizations that are subsequently found to be unable to accept funding directly from Pfizer Inc. may be subject to rescission
  About: Aims to support IBD related research initiatives focused on following:
  Precision medicine approach which is the tailoring of medical treatment to the individual patient, encompassing a multitude of data-driven (including multi-omic) approaches to foster appropriate clinical decision-making. Examples would include:
  Identifying clinical or laboratory characteristics of patients who have mild disease or remain in long-term remission, and studying whether patients with comorbidities have a different disease course
  Collecting data on access to care for patients from underserved communities in order to tailor treatments more specifically o Meta-analysis or Systematic Literature Review (SLR) to further characterise potential differences underrepresented groups vs. general population in terms of disease course or treatment response
  Research on ways to improve IBD management among underserved groups, such as treat to target approaches
  Studies quantifying the socio-economic and psycological burden of IBD and its correlation with social determinants of health
• OREF Mentored Clinician Scientist Grant
  Amount: $20,000 over 1 year
  Deadline: October 12, 2023
  Eligibility: The applicant must demonstrate success in research by receiving extramural research funding under one or more K08 or K23 awards from the National Institutes of Health (NIH), or an equivalent funding source. The grant is renewable annually for up to five (5) years, equal to the term of the research funding, subject to annual review of the scientific progress of the research project and available OREF funding.
  About: Promotes the development of new clinician scientists who have demonstrated success as both a clinician and a researcher. Allows investigators to spend dedicated time in research for a period of up to five years to develop a long and productive career in academic surgery.
• Angelman Syndrome Foundation
  Amount: $200,000 over 2 years
  Deadline: October 15, 2023; April 15, 2024
  About: Priority will be given to the following topics:
  Projects studying or correcting the heterozygous effect of non-UBE3A genes in deletion.
  Projects studying the potential results of increasing UBE3A after therapies or for some subtypes of AS.
  Projects studying delivery of therapies and potential for improvement.
  Symptomatic therapies that impact the daily life of people with Angelman syndrome and their families.
• American Cancer Society: Advancing Health Equity and Addressing Cancer Disparities Award
  Amount: $250,000 over 2 years (+20% indirect costs)
  Deadline: October 16, 2023
  Eligibility: The principal investigator must:
  Have a doctoral degree
  Work at a US academic institution or eligible non-profit organization
  Have an independent faculty appointment (or equivalent position)
  About: Funds exploratory, novel research studies that seek to improve access to quality cancer screening and/or cancer care by bringing technologies to individuals rather than requiring travel to healthcare facilities. A scientist’s proposed research may break new ground or strategize a new application of existing technologies or new intervention. We encourage the testing of high-risk, high-reward pilot projects to maximize the likelihood for breakthrough research and critical impact.
• Burroughs Wellcome Fund: Career Awards for Medical Scientists
  Amount: $700,000 over 5 years
  Deadline: October 17, 2023
  Eligibility: Competitive candidates for the CAMS award will:
  Have at least 2 years of research experience
  Be up to 2 years away from becoming an independent investigator
  Be a first author on at least one publication in a peer-reviewed journal and have a significant publication record.
  Candidates must hold an M.D., D.D.S., D.V.M., V.M.D., or D.O. degree.
  Candidates must have completed clinical training (residency or fellowship) and be board eligible by the award start date.
  Candidates may hold a junior faculty appointment (Lecturer, Instructor, Assistant Professor-non-tenure track, etc.).
  At the time of application, candidates cannot hold nor have accepted, either in writing or verbally, a faculty appointment as a tenure track Assistant Professor.
  Candidates that have non-tenure track faculty appointments and have been awarded an NIH R01 or Early Independence Investigator award(s), including NIH K99 or NIH DP5 award, are not eligible. Those with substantial institutional start up packages are also ineligible.
  If applicable, an authorized official at the degree granting institution must verify candidate’s immigration status as part of the application.
  The primary mentor or faculty sponsor of a candidate must hold an appointment at the same accredited, degree-granting institution as the applicant.
  Candidates who are temporary U.S. residents must hold a valid U.S. visa (J-1, H1B, F-1 or O-1 visas).
  As a candidate, your visa status must allow you to remain in the U.S. or Canada during the award period of the CAMS grant.
  Proposals must be in the area of basic biomedical, disease-oriented, or translational research.
  Proposals in health services research or involving large-scale clinical trials will not be considered.
  Candidates must be committed to a full-time career in research as an independent investigator at a North American degree-granting institution.
  Award recipients are required to devote at least 75% of their time to research-related activities.
  About: Provides support to facilitate the transition from mentored position to independence for the early career physician scientist. The program is ideal for the physician scientist considering an academic career.
• Melanoma Research Alliance: Dermatology Career Development Award
  Amount: Up to $150,000 over 2 years
  Deadline: Applicant Eligibility Checklist due October 20, 2023
  Eligibility:
  Applicants must have a doctoral degree (M.D., D.O. and/or Ph.D.) by the date of award activation.
  It is preferred that applicants conduct their proposed research/project in the host institution’s Department/Division of Dermatology. MRA will consider applicants in Departments from other clinical fields involved in the treatment of melanoma (e.g. medical oncology, surgery, immunology, dermatopathology, pathology, bioengineering).
  Applicants may hold the title of Junior Faculty, Clinical Instructor, Assistant Professor, or a similar title used by their institution to describe early career faculty.
  Applicants in a Fellowship position may apply if they are board eligible or board certified in Dermatology, Dermatopathology and/or Micrographic Surgery and Dermatologic Oncology (i.e. Mohs micrographic surgery/procedural dermatology). Trainees (i.e. med students, residents, grad students, or postdocs) are not eligible to apply.
  Applicants with full academic faculty appointments (i.e. Assistant Professors or equivalent) must be within the first five years of their first independent, full time academic faculty appointment at the application deadline. Assistant Professors on a clinical, tenure, or research track will be accepted.
  Applicants who have secured an eligible position commencing by June 1, 2024 will be considered; in this case, a letter from an institutional official or department chairperson confirming the planned date of faculty appointment is required at the time of application.
  Applicants must designate at least one Mentor who is an established investigator.
  Applicants who have been awarded a prior MRA Young Investigator Award are not eligible to apply.
  Applicants may serve as PI on only one proposal submitted to MRA for any of the award mechanisms in this cycle
  About: Aims to attract early career faculty and clinical research fellows in departments or divisions of dermatology with original ideas into the field of melanoma, thereby recruiting and supporting the next generation of melanoma research leaders. This award will support research projects (including epidemiological data gaps and population health and education programs), practice changing demonstration projects, and/or immersive studies aimed at improving melanoma prevention, early detection, diagnosis, and/or staging. In pursuit of this goal, MRA welcomes proposals with immediate real-world implications for public health, prevention, and/or clinical practice. MRA also encourages the application of artificial intelligence (AI) across any of these areas, especially to reduce variable biopsy-referral and/or diagnostic standards.
• Melanoma Research Alliance: Young Investigator Award
  Amount: Up to $255,000 over 3 years
  Deadline: Applicant Eligibility Checklist due October 20, 2023
  Eligibility: Applicants must:
  Be within the first five years of their first independent, full time academic faculty appointment at the application deadline, at the level of Assistant Professor (or equivalent position);
  Designate at least one Mentor who is an established investigator
  Applicants who have secured an independent full-time faculty position commencing by June 1, 2024 will be considered; in this case, a letter from an institutional official or department chairperson confirming the planned date of faculty appointment is required at the time of application;
  Applicants do not have to be on a tenure-track; however, fellows or others who are in training positions are not eligible to apply;
  Applicants who are in research support positions are not eligible to apply;
  Applicants who have been awarded a prior MRA Young Investigator Award are not eligible to apply for an additional MRA Young Investigator Award;
  Applicants may serve as PI on only one proposal submitted to MRA for any of the award mechanisms in this cycle.
  About: This award aims to attract early career faculty with original ideas into the field of melanoma, thereby recruiting and supporting the next generation of melanoma research leaders.
• American Sleep Medicine Foundation: Strategic Research Award
  Amount:
  Category I: $250,000 over 3 years.
  Category II: $100,000 over 2 years.
  Category III: $50,000 over 1 year.
  Deadline: LOI due October 23, 2023
  Eligibility: Sleep scientists with a master’s level degree or higher are eligible to apply. Individuals may apply for multiple AASM Foundation grants, however, the same proposal (i.e., projects with budgetary and scientific overlap) may not be submitted for multiple requests for applications in a given cycle. Additionally, if an individual submits more than one application in a given Career Development Grant cycle, the AASM Foundation will only approve funding one grant should multiple proposals submitted by the applicant receive a competitive score. Individuals who are the Principal Investigator on an open AASM Foundation research grant at the time of the application deadline are eligible to apply if they can demonstrate that there is no budgetary or scientific overlap between their open grant and the new project they are applying for funding. If there is budgetary and/or scientific overlap between projects, the applicant must indicate their plan to close their open grant in the event their new application is selected for funding (e.g., relinquish the current grant or complete the current grant to start the new grant). International individuals who meet all the eligibility criteria are eligible to apply; however, payment of grant funds must be accepted by the institution in US dollars.
  About: This award supports high-impact research projects aimed at addressing gaps in knowledge that impact the ability to provide optimal, patient-centered, cost-effective diagnosis and care for patients with sleep disorders.
• American Association of Critical Care Nurses: Impact Research Grant
  Amount: $50,000
  Deadline: Friday, October 27, 2023
  Eligibility: Principal investigators must hold an earned master’s degree or have completed candidacy requirements in a BSN-to-PhD or DNP program. Current AACN membership is required. Principal investigators must be registered nurses holding current AACN membership at the time of submission and must remain AACN members throughout the life of the grant funding.
  About: The AACN Impact Research Grant addresses gaps in high-acuity and critical care areas of clinical research. The grants will ensure the pipeline for research that is vital to AACN’s research translation resources, such as protocols and practice alerts. These grants will also facilitate research to support other AACN priorities, such as describing the impact of family presence, influencing nurse certification and implementing standards for healthy work environments.
• CIFAR Azrieli Global Scholars Program
  Amount: CAD 100,000 over 2 years
  Deadline: October 30, 2023
  Eligibility:
  Hold a PhD (or equivalent).
  Be employed at an institution of higher education or research and be within the first five years of starting a full-time position that includes responsibility for both conducting an independent research program and supervising/teaching trainees toward the completion of a degree.
  Typically, you are an Assistant Professor in the North American system or the equivalent in other academic systems around the world. Some examples of accepted positions include, but are not limited to: Level B Lecturer or Research Fellow (Australia); Chargé de Cours or Docent (Belgium); Professor adjunto (Brazil); Maître de Conférences (France); Junior Professor or Research Group Leader (Germany); Ricercatore Tipo A and B (Italy); Profesor Titular A (Mexico); Universitair Docent (Netherlands); Ramón y Cajal Scholar (Spain); Lecturer (United Kingdom, Israel).
  Your position must be secure for the duration of the CIFAR Azrieli Global Scholar active term (to March 31, 2026).
  Your start date in this position must be no earlier than July 1, 2019. Note that special consideration may be given to those who have taken parental leave or have exceptional circumstances.
  NOTE: Postdoctoral fellows are NOT eligible to apply to this program, with the following exception:
  If you have a pending first full-time position that meets the criteria above and starts no later than July 1, 2024, you are eligible to apply. In this case, you must submit a copy of your letter of appointment with your application.
  Engage in research that complements the themes and goals of a recruiting CIFAR research program (see page 5).
  Demonstrate an outstanding level of research achievement and promise of future impact in your field, as evidenced by the quality of your publications, awards received, and statements by referees.
  Be motivated to engage across disciplines, as well as sectors beyond academia, to enrich and extend the impact of your research.
  Be available to attend a virtual interview between March 20-21, 2024.
  Have a valid passport, and if required, be able to obtain travel visas to attend CIFAR meetings around the world (2-3 times per year)
  About: Designed to accelerate the development of early-career researchers in their pivotal first years as independent principal investigators in an academic or research institution, with responsibilities for research and teaching.
• Mike Utley Foundation
  Deadline: November 1, 2023
  Amount: $20,000
  About: The purpose of the Foundation is to financially support select research, rehabilitation and education for those living with spinal cord injuries. Awards are granted in the following areas:
  Select research for the development of pharmaceutical or biological methods to improve function in acute or chronic spinal cord injuries. Preference will be given to investigators with established programs in adult stem cell research.
  Funding of Rehabilitation Institutions for research, equipment purchases, patient assistance programs and durable medical equipment.
• Fibrolamellar Cancer Foundation: Research Grant Application
  Amount: Up to $400,000 over 2 years
  Deadline: November 1, 2023
  Eligibility:
  Applicants must be employed by an institution engaged in health-related research. Applicants further must agree to be supervised by the institution at all times while conducting research supported by the FCF. In cases of a change in institution while applying for, or utilizing funds from the FCF, applicants must notify the FCF. Continuation of the grant award will be subject to review based upon the change in circumstances.
  The research must focus on Fibrolamellar Carcinoma (FLC) [aka Fibrolamellar Hepatocellular Carcinoma (FL-HCC)]. Studies should be intended to advance knowledge relevant to the understanding, diagnosis, epidemiology, or treatment of FLC. Of particular interest are applications showing a clear path towards a novel therapy / clinical trials with the ultimate goal of achieving a cure for FLC. The FCF will accept grant applications to support innovative and promising research projects towards the above goals.
  Collaboration and open sourcing. This is a requirement for funding by the FCF and will be so specified in any grant agreement. The FCF believes that collaboration engaging the best talent across institutions, together with early sharing of data and resources, often accelerates the path to a cure for rare cancers.
  About: Supports the funding of research related to Fibrolamellar Carcinoma.
• American Otological Society: Clinician-Scientist Award
  Amount: Up to $240,000 over 3 years
  Deadline: LOI due November 1, 2023
  Eligibility: Candidates for this award must:
  Have completed an ACGME-approved residency in Otolaryngology-Head and Neck Surgery and
  Hold a full-time teaching appointment in a US medical school within a department or division of Otolaryngology-Head and Neck Surgery
  Be citizens of the United States, or have been lawfully admitted for permanent United States residency at the time of application;
  Hold a Doctor of Medicine (MD) or equivalent degree from an accredited institution awarded within the last 10 years; and
  Have demonstrated the capacity or potential for a highly productive, independent research career with an emphasis in otology/neurotology.
  All candidates must be sponsored by the Chair of his/her Division or Department, and by an official representative of the institution which would administer the award and in whose name the application is formally submitted.
  The applicant is responsible for selecting a research mentor at the academic institution to which the award will be made, and for making arrangements to work with that person. The designated mentor must be the faculty member who will directly supervise the proposed research training and evaluate the awardee’s progress.
  Preference will be given to candidates who have recently (within the preceding three years) completed or are currently enrolled in a two-year otology/neurotology fellowship. The AOS Clinician-Scientist and his or her mentor(s) are encouraged to use preliminary research results from this award as pilot material for the development of a research grant application to a suitable funding agency. Specifically, this grant mechanism is designed to permit the budding clinician-scientist adequate time and mentoring to accrue preliminary data to successfully apply for a K08/K23 grant from the NIH. Therefore, individuals who have already competed successfully for a career development award from a private or Federal funding agency are ineligible for this award program. The grantee may not receive concurrent research salary support from other agencies or sources during the period of this grant. Accordingly, funding from the AOS will be terminated once the Clinician-Scientist secures Federal funding for a Career Development Award.
  About: Supports full-time teachers at the junior level who are aiming to develop a career as a clinician-scientist.
• American Otological Society: Clinical Investigations Grant
  Amount: Up to $66,000 over 1 year
  Deadline: LOI due November 1, 2023
  Eligibility:
  These grants are available to physician or doctoral-level investigators in the United States and Canada only. Specific funding criteria are given on Table 1 in full RFP.
  A research proposal will qualify for review when it involves studies that pertain to the function or dysfunction of the ear, specifically the auditory and/or vestibular system.
  About: Supports studies that pertain to the function or dysfunction of the ear, specifically the auditory and/or vestibular system.
• American Otological Society: Research Grant
  Amount: Up to $55,000 over 1 year
  Deadline: LOI due November 1, 2023
  Eligibility:
  These grants are available to physician or doctoral-level investigators in the United States and Canada only. Specific funding criteria are given in Table 1.
  Faculty, either MD or PhD
  A research proposal will qualify for review when it involves studies that pertain to the function or dysfunction of the ear, specifically the auditory and/or vestibular system. A statement is to be included under the Research Plan explaining how the proposed research will benefit our understanding, diagnosis or treatment of otological disorders.
  About: Supports studies that pertain to the function or dysfunction of the ear, specifically the auditory and/or vestibular system.
• American Otological Society: Fellowship Grant
  Amount: Up to $44,000 over 1 year
  Deadline: LOI due November 1, 2023
  Eligibility:
  These grants are available to physician or doctoral-level investigators in the United States and Canada only. Specific funding criteria are given in Table 1.
  Clinical fellows, residents, post-doctoral fellows (both MD and PhD), and graduate students
  A research proposal will qualify for review when it involves studies that pertain to the function or dysfunction of the ear, specifically the auditory and/or vestibular system. A statement is to be included under the Research Plan explaining how the proposed research will benefit our understanding, diagnosis or treatment of otological disorders.
  About: Supports studies that pertain to the function or dysfunction of the ear, specifically the auditory and/or vestibular system.
• Robert Wood Johnson Foundation: Health Policy Fellows
  Amount: Up to $175,000 over 1-2 years
  Deadline: Preliminary Application due November 1, 2023
  Eligibility:
  Exceptional midcareer professionals from academic institutions, not-for-profit organizations, or government
  Applicants must have earned an advanced degree (masters or doctoral degree);
  Applicants must have deep experience and subject matter expertise in a health-related discipline.
  Applicants whose official job description or responsibilities are primarily government relations or advocacy are not eligible;
  Individual candidates for receipt of award funds must be U.S. citizens, or permanent residents at the time of application. Because the RWJF Health Policy Fellows are placed in assignments in the federal government, changes in federal policy or law may necessitate that RWJF consider adjustments in eligibility and grant terms, as well as placements in the program.
  About: Provides the nation’s most comprehensive learning experience at the nexus of health, science, and policy in Washington, D.C. It is an outstanding opportunity for exceptional midcareer health professionals and behavioral/social scientists with an interest in advancing health and health equity through policy change. Fellows participate in the policy process at the federal level and leverage that leadership experience to promote policies, practices, and systems changes that advance health and health equity.
• Melanoma Research Alliance: Pilot Award
  Amount: Up to $100,000 over 2 years
  Deadline: November 3, 2023
  Eligibility: Applicants must be a senior investigator, past the initial five years of their first academic faculty appointment; Applicants must hold a full-time faculty appointment at the level of Assistant Professor (or equivalent) or above.
  About: Support senior investigators who propose potentially transformative ideas that do not have extensive preliminary data but articulate a clear hypothesis and translational goals. Resources for such “high-risk, high-reward” projects are important to establish proof-of-concept, which may then leverage additional funding through more traditional avenues.
• Gordon and Betty Moore Foundation: Inventor Fellows
  Amount: Up to $675,000 over 3 years
  Deadline: November 14, 2023
  Eligibility:
  Areas of interest: scientific discovery, environmental conservation and patient care.
  Open only to faculty, postdocs, and staff at eligible institutions.
  All candidates must be no more than 10 years past receiving their Ph.D., M.D., M.S., or other terminal degree in their field from when the award will begin (2024 – a degree received on any date in 2014 is acceptable).
  All candidates must be within 10 years of receiving their Ph.D. or other terminal degree. However, a degree received on any date in 2014 is acceptable.
  Fellows must be engaged in the pursuit of their invention at least 25 percent time for the three-year duration of the award. Flexibility in effort allocation is permissible as long as the total for the award equals at least 25 percent of academic effort. This does not refer to the candidate’s own time outside of the lab.
  About: Supporting scientist-inventors at a critical prototyping stage to capture opportunities that otherwise might be missed. We seek to provide freedom and support to promising inventors with the most compelling ideas to pursue creative and disruptive innovations.
• Gerber Foundation: Pediatric Health Research Grants
  Amount: Up to $350,000 over 3 years
  Deadline: Concept paper due November 15, 2023
  Eligibility: Organizations recognized as tax-exempt under Internal Revenue Code 501(c)(3) are eligible to apply for Foundation grants. Public governmental institutions such as universities are included in this definition. Organizations must also be determined not to be private foundations under Internal Revenue Code 509. No grants are made to individuals. With few exceptions, only organizations with principal operations in the United States and its territories are eligible for funding. Within the United States, there is no geographic limitation to the Foundation’s grantmaking. See the FAQ page for grant specifics and limitations.
  About: Supports health and/or nutrition-related research projects with potential to have a significant impact on issues affecting infants and young children from birth to three years of age.
• American Foundation for Suicide Prevention: Distinguished Investigator Innovation Grants
  Amount: Up to $150,000 over 2 years
  Deadline: November 15, 2023
  Eligibility:
  Must be at the level of associate professor or higher with an established record of research and publications.
  At least one suicide outcome measure must be included in all grant projects. We also consider studies of treatment feasibility, and studies that add a suicide component (e.g., population or treatment) to an existing grant in another area.
  Investigators from all academic disciplines are eligible to apply, and both basic science and applied research projects will be considered, provided that the proposed study has an essential focus on suicide or suicide prevention.
  A current grantee may submit a new application as their grant nears completion but it will not be funded until completion of the current grant and submission of a Final Report.
  New grantees must begin their studies within 6 months of the approved start date. Failure to begin the study within this time frame may result in withdrawal of the grant award.
  About: Supports studies that will increase our understanding of suicide or test treatments and other interventions that save lives.
• American Foundation for Suicide Prevention: Early Career Researcher Innovation Grants
  Amount: Up to $140,000 over 2 years
  Deadline: November 15, 2023
  Eligibility:
  Must be at or below the level of assistant professor.
  Applicants for an Early Career Research Grant cannot have had an NIMH or federal R01 grant or its equivalent.
  Must allocate $14,000 ($7,000 per year) of their award for an established researcher to mentor the Early Career Researcher.
  At least one suicide outcome measure must be included in all grant projects. We also consider studies of treatment feasibility, and studies that add a suicide component (e.g., population or treatment) to an existing grant in another area.
  Investigators from all academic disciplines are eligible to apply, and both basic science and applied research projects will be considered, provided that the proposed study has an essential focus on suicide or suicide prevention.
  A current grantee may submit a new application as their grant nears completion but it will not be funded until completion of the current grant and submission of a Final Report.
  New grantees must begin their studies within 6 months of the approved start date. Failure to begin the study within this time frame may result in withdrawal of the grant award.
  About: Supports new researchers to obtain the advice, guidance and supervision of an established mentor in a selected area of suicide research.
• American Foundation for Suicide Prevention: Postdoctoral Research Fellowship Innovation Grants
  Amount: Up to $140,000 over 2 years
  Deadline: November 15, 2023
  Eligibility:
  Must have received a Ph.D., M.D., or other doctoral degree within the preceding six years and have had no more than three years of fellowship support.
  Postdoctoral Research Fellowships are awarded to individuals who will be receiving training and conducting research at universities and other training institutions in the U.S. and abroad.
  Fellowship applicants must have completed all requirements for a Ph.D., M.D., or other doctoral degree prior to the start date of the Postdoctoral Research Fellowship. Individuals who have three or more academic years of postdoctoral fellowship research experience prior to the time the Postdoctoral Research Fellowship would begin are not eligible for this award.
  An AFSP Postdoctoral Research Fellowship may not be held concurrently with any other postdoctoral fellowship. Additional funds may be secured by the Fellow to support costs associated with the research project.
  Although it is the general policy of AFSP that individuals may be the Principal Investigator on only one AFSP grant at a time, individuals holding an AFSP Postdoctoral Research Fellowship are eligible to receive additional funds through an AFSP Pilot Research Grant to support costs associated with the research project (as distinct from salary support or the Institutional Allowance, as described below). Fellows may apply for a Pilot Research Grant at any point during the Fellowship period (See AFSP Policies for Pilot Research Grants).
  Recipients of the AFSP Postdoctoral Research Fellowship may not reapply for this award.
  At least one suicide outcome measure must be included in all grant projects. We also consider studies of treatment feasibility, and studies that add a suicide component (e.g., population or treatment) to an existing grant in another area.
  Investigators from all academic disciplines are eligible to apply, and both basic science and applied research projects will be considered, provided that the proposed study has an essential focus on suicide or suicide prevention.
  A current grantee may submit a new application as their grant nears completion but it will not be funded until completion of the current grant and submission of a Final Report.
  About: Supports early career researchers to qualify for independent careers in suicide research.
• American Foundation for Suicide Prevention: Standard Research Innovation Grants
  Amount: Up to $125,000 over 2 years
  Deadline: November 15, 2023
  Eligibility:
  For investigators at any level
  At least one suicide outcome measure must be included in all grant projects. We also consider studies of treatment feasibility, and studies that add a suicide component (e.g., population or treatment) to an existing grant in another area.
  Investigators from all academic disciplines are eligible to apply, and both basic science and applied research projects will be considered, provided that the proposed study has an essential focus on suicide or suicide prevention.
  A current grantee may submit a new application as their grant nears completion but it will not be funded until completion of the current grant and submission of a Final Report.
  New grantees must begin their studies within 6 months of the approved start date. Failure to begin the study within this time frame may result in withdrawal of the grant award.
  About: Intended to fund new directions and initiatives in suicide research
• American Foundation for Suicide Prevention: Pilot Innovation Grants
  Amount: Up to $50,000 over 2 years
  Deadline: November 15, 2023
  Eligibility:
  At least one suicide outcome measure must be included in all grant projects. We also consider studies of treatment feasibility, and studies that add a suicide component (e.g., population or treatment) to an existing grant in another area.
  Investigators from all academic disciplines are eligible to apply, and both basic science and applied research projects will be considered, provided that the proposed study has an essential focus on suicide or suicide prevention.
  A current grantee may submit a new application as their grant nears completion but it will not be funded until completion of the current grant and submission of a Final Report.
  New grantees must begin their studies within 6 months of the approved start date. Failure to begin the study within this time frame may result in withdrawal of the grant award.
  About: Supports studies that will increase our understanding of suicide or test treatments and other interventions that save lives; provides seed funding for new projects that have the potential to lead to larger investigations. These grants typically entail feasibility studies rather than hypothesis-driven research. Examples include manual development and new biomarker development.
• American Society of Clinical Oncology: Conquer Cancer – Breast Cancer Research Foundation Advanced Clinical Research Award
  Amount: $450,000 over 3 years
  Deadline: LOI due November 16, 2023
  Eligibility: Applicants must meet the following criteria for the ACRA for Diversity and Inclusion in Breast Cancer Research:
  Self-identify as a member of a racial and/or ethnic group traditionally excluded in academic medicine according to the AAMC definition (include but are not limited to: American Indian/Alaska Native, Black/African American, Hispanic/Latino, and Native Hawaiian/Other Pacific Islander). Individual demographic information will be requested upon application.
  Be a physician (MD, DO, or international equivalent).
  Have completed productive post-doctoral/post fellowship research and demonstrated the ability to undertake independent investigator-initiated clinical research in breast cancer.
  At mid-career level, normally between five to ten years from the first, full-time, primary faculty appointment in a clinical department at an academic medical institution by the application deadline.
  Be an ASCO member or have submitted a membership application with the grant application.
  Be able to commit 75 percent of full-time effort in research (applies to total research, not just the proposed project) during the award period.
  About: Designed with the primary goal of increasing diversity in the oncology workforce and cancer research.
• U.S.-Israel Binational Science Foundation Research Grants
  Amount: Up to $250,000 over 4 years
  Deadline: November 29, 2023
  Eligibility:
  The PIs must have obtained a PhD, an MD, or an equivalent degree.
  The PIs must be faculty members or equivalent.
  Eligible research areas are biomedical engineering, psychobiology, life sciences, medicine
  BSF only funds scientists from institutions of higher learning, government research institutions, hospitals and other non-profit research organizations.
  Applications by for-profit organizations are not allowed, but a scientist who is affiliated with such an organization may be an applicant on a BSF proposal, if the organization is committed to funding the PI’s part in the research.
  Each PI may only submit one application per year to the BSF Research Grants program.
  An investigator can only hold one BSF research grant at any given time, and may submit a new application only in the last year of a current grant. However, he or she can hold concurrently a different type of a BSF award, such as an NSF-BSF grant.
  U.S. government scientists who seek funding from the BSF must consult the BSF office before committing to the research program, as U.S. government institutions often refuse to sign the standard BSF contract.
  Collaborative Research
  Cooperative research is a fundamental requirement for the BSF and is viewed by the Foundation as active collaboration between Israeli and U.S. scientists.
  Cooperation should involve joint planning of research, data gathering and evaluation of results, and may take the form of:
  Joint research activities, where interdependent projects of a single program are conducted in different laboratories
  Provision of research facilities, materials, equipment, and/or services to cooperating scientists
  Exchange of personnel.
  About: Funds both U.S. and Israeli scientists who wish to collaborate on research projects that address topics in biomedical engineering, psychobiology, life sciences, and medicine.
• Autoimmune Liver Diseases Exploratory Research Award
  Amount: $20,000 over 1 year
  Deadline: December 04, 2023
  Eligibility:
  Be at the pre-doctoral/graduate level, post-doctoral level, or junior faculty within the first five years of their first faculty appointment (including prior appointments in universities outside of North America) at the start of the award (faculty appointment starting no earlier than July 1, 2019).
  Be a member of the American Association for the Study of Liver Diseases (AASLD) at the time of award application and maintain active membership for the duration of the award period.
  Be able to devote at least 20% effort to research activities related to this award.
  Be sponsored by a public or private non-profit institution accredited in the United States, Canada or Mexico engaged in health care and health-related research. Individuals employed at the NIH, FDA, and CDC are not eligible to apply.
  Have a mentor or co-mentor who is an AASLD member in good standing at the time of application and for the duration of the award period.
  The proposed project must:
  Focus on research pertaining to the pathogenesis, diagnosis, management, or outcome of autoimmune liver diseases in children and/or adults.
  Not be an established project with alternate funding.
  Be conducted at the sponsoring institution within the United States, Canada or Mexico.
  Application limits:
  There is no restriction on the number of applicants an institution can sponsor each cycle, but only one applicant may be funded per distinct department within each institution in this award category.
  Applicants may only apply for one AASLD Foundation research award per calendar year. Eligible applicants in this category may also apply for the AASLD Foundation Advanced/Transplant Hepatology Award in the same calendar year.
  About: Provide supplementary funding during the pilot/exploratory phase of basic, translational or clinical research projects in autoimmune liver disease (e.g., autoimmune hepatitis, primary sclerosing cholangitis, primary biliary cholangitis) in preparation for future grant applications by the recipient.
• AHSP: Collaborative Care Grant for Nurses and Pharmacists
  Amount: $75,000 over 18 months
  Deadline: December 10, 2023
  Eligibility:
  Problem or opportunity in practice related to optimizing medication use and outcomes.
  Nurse and pharmacist to serve as co-principal investigators.
  Proposal to include: the problem in practice and aim(s), the rational and significance, expected outcomes, methods and plan, and baseline and target measures for each outcome. Priority Considerations
  Proposals that are patient-centered, such as, decrease patient harm; increase patient involvement in care; improve care transitions; reduce hospital admissions; improve quality of life; and optimize resource utilization for patients with multiple co-morbidities.
  Eligible Research
  Innovating or evaluating new services or technologies to minimize barriers to care for populations such as at-risk or complex patients from underserved communities, or individuals who are elderly, have comorbidities or require chronic care.
  Focusing on complex systems and processes (e.g., emergency departments), transitions of care, continuums of care, preventative care.
  Priority to be given to research that measures teamwork and meaningful outcomes, such as, decreased patient harm, increased patient involvement in care, reduced hospital admissions/readmissions, and improved quality of life.
  Research that includes an aim and outcomes to support creating a more diverse, inclusive, and equitable healthcare system.
  Preference for projects that include measurement of team-based care or team-functioning, as well as problem-specific measures.
  About: Supports patient-centered interprofessional health services research that demonstrates meaningful outcomes
• Melanoma Research Foundation: Mid-Career Bridge Grants
  Amount: $100,000 over 1 year
  Deadline: December 15, 2023
  Eligibility:
  Applicants must hold a MD and/or PhD degree or equivalent.
  Applicants must be within 15-years of obtaining their first independent position (e.g. as an instructor, assistant professor, etc.) AND previously held a R01 during this time period.
  Applicants must have submitted a NIH R01 application within the past 6 months that was scored but not funded. The 6-month timeframe begins the date the R01 was reviewed by the NIH study section. The MRF will accept either an original R01 or a resubmission application as the underlying basis for this award.
  The scored, but not funded, NIH R01 must have achieved a percentile of 40 or lower/better on the A0 application. P01s/R21s/etc. will not be eligible for this grant mechanism.
  The applicant must be the contact Principal Investigator (PI) on the original R01 to qualify for this award.
  The application must focus on melanoma research.
  Priority will be given to those applicants who do not have other funding sources.
  Individuals cannot apply for the MRF Mid-Career Bridge Grant more than three times for the same R01.
  Applicants are eligible to respond to other MRF RFPs, as long as the research proposals are significantly different.
  Proposed research must comply with all applicable National Institutes of Health (NIH) animal and human welfare guidelines.
  Applicants are encouraged to discuss any eligibility questions with the MRF Science Officer prior to submitting an application.
  About: Support investigators who are dedicated to melanoma research. Investigators who have received their first R01 often have difficulty obtaining their second one. This award will be for established researchers with a pre-existing R01s, who have applied for a second NIH R01 grant that was scored, but not funded
• Whitehall Foundation Basic Biological Research Grants
  Amount: $150,000 over 2 years
  Deadline: LOI due January 15, 2024
  Eligibility: The applicant must meet all of the following eligibility requirements in order to participate in the application process:
  Appropriate title – must be an Assistant Professor (or higher). If the institution does not use this title, a letter from the department chair confirming the applicant’s eligibility is required.
  Status – must hold Principal Investigator status.
  Independent – must be considered an ‘independent investigator’ with their own dedicated lab space or with lab space independent of another investigator.
  The Foundation does not fund investigators who have substantial (approximately $200,000 per year) extramural funding. The Foundation uses the following formula to determine the PIs total extramural funding: Total direct per year plus total indirect per year less any PI salary taken from these grants. If this amount is greater than approximately $200,000 the PI would not be eligible for Whitehall Foundation funding. Startup funds and internal funding are not included in the calculation.
  About: The Foundation is currently interested in basic research in neurobiology, defined as follows: Invertebrate and vertebrate (excluding clinical) neurobiology, specifically investigations of neural mechanisms involved in sensory, motor, and other complex functions of the whole organism as these relate to behavior. The overall goal should be to better understand behavioral output or brain mechanisms of behavior.
• Lennox-Gastaut Syndrome Foundation: Cure LGS 365 Research Grants
  Deadline: LOIs due May 1, 2024, with rolling decisions
  Amount: $25,000-75,000
  About: Projects may be on any novel topic in LGS but must be directly relevant to LGS, which is characterized by specific seizure types and hallmark EEG features.
• American Association of Neurological Surgeons: William P. Van Wagenen Fellowship
  Deadline: November 1, 2024
  Amount: $120,000 over 1 yr
  Eligibility: The fellowship is open to all senior neurosurgical residents (PGY6 & PGY7) in approved neurosurgery residency programs whose intent is to pursue an academic career in neurological surgery. It is offered strictly as a post-residency fellowship.
• Cystic Fibrosis Foundation: Therapeutics Development Award
  Deadline: rolling
  In an effort to stimulate development of new pharmaceutical products for CF patients, CFF developed the “Therapeutics Development Award” Program. The purpose of this program is to provide funds to companies that will develop commercial products to benefit individuals with CF. Structured as a matching award program, funds will be awarded only if they are matched by the recipient.
• Foundation Fighting Blindness: Ted and Elaine Welp Enhanced Career Development Program Award (Enhanced CDA)
  Rolling Submission
  Amount/Duration: $170,000 per year for up to three years.
  Eligibility: Applicants must possess an M.D. or M.D./Ph.D. degree, hold a full-time tenure-track or equivalent appointment at the sponsoring institution with a commitment of no less than five (5) years, commit at least 80% of their work hours to the program, and have successfully completed an ophthalmology residency or equivalent training.
  About: The Enhanced CDA ensures that an adequate pool of highly trained physicians/scientists are available to address current and future needs and opportunities for clinical research and therapy related to inherited orphan retinal degenerative diseases. This award supports and provides protected career development time to individuals with M.D. and M.D./Ph.D. degrees to further their independent research in retinal degenerative diseases.
• Robert Wood Johnson: research to advance racial equity
  Deadline: rolling
  Amount: no max listed
  About: This funding is focused on studies about upstream causes of health inequities, such as the systems, structures, laws, policies, norms, and practices that determine the distribution of resources and opportunities, which in turn influence individuals’ options and behaviors. Research should center on the needs and experiences of communities exhibiting the greatest health burdens and be motivated by real-world priorities. It should be able to inform a specific course of action and/or establish beneficial practices, not stop at characterizing or documenting the extent of a problem.
• Simons Foundation: Autism Research Initiative SFARI Supplement to Enhance Equity and Diversity (SEED)
  Rolling Submissions
  Amount/Duration: Up to $100,000 per year for up to 3 years.
  About: The SFARI Supplement to Enhance Equity and Diversity (SEED) is a new program that provides supplements to existing grants for the recruitment of new lab members from American underrepresented minority groups at the postdoctoral level. The goal of this award is to increase diversity and fight inequity. SFARI Principal Investigators (PIs) are encouraged to recruit candidates for this supplement not only at their home institution but also at historically Black colleges and universities and other institutions with high minority enrollment.
• How to Apply – Warner Fund
  Deadline: Rolling
  Amount: $75,000
  About: seeks to provide support for programs designed improve the lives of children in foster care and children with disabilities. The Warner Fund gives preference to innovative projects with measurable results and the likelihood of replication. Funding will only be considered after a comprehensive sustainability plan with a timeline of events has been developed and submitted for review.
• PNC Foundation: Grow up great
  Deadline: rolling deadline
  Amount: $50,000-100,000
  About: Educational programs for children and youth, particularly early education initiatives supported through PNC Grow Up Great that serve low-and moderate-income children (birth through age five), their teachers and families may be considered for funding.